Table 2.
Genotype frequency of thrombophilias.
| SNP | Genotype | Cases, n (%) | Controls, n (%) | OR (CI 95%) |
|---|---|---|---|---|
| FV Leiden | GG (normal) | 92 (98.9%) | 205 (99.5%) | 0.4 (0–16.44) |
| GA | 1 (1.1%) | 1 (0.5%) | 2.2 (0–83) | |
| AA | 0 | 0 | ND | |
|
| ||||
| Total | 93 (100%) | 206 (100%) | ||
|
| ||||
| FII G20210A | GG (normal) | 92 (98.9%) | 205 (99.5%) | 0.4 (0–16.4) |
| GA | 1 (1.1%) | 1 (0.5%) | 2.2 (0–83) | |
| AA | 0 | 0 | ND | |
|
| ||||
| Total | 93 (100%) | 206 (100%) | ||
|
| ||||
| MTHFR C677T | CC (normal) | 38 (40.9%) | 93 (45.1%) | 0.8 (0.5–1.4) |
| CT | 43 (46.2%) | 83 (40%) | 1.3 (0.8–2.1) | |
| TT | 12 (12.9%) | 30 (14.9%) | 0.8 (0.4–1.8) | |
|
| ||||
| Total | 93 (100%) | 206 (100%) | ||
SNP: single nucleotide polymorphism; n: number of women; OR: odds ratio; CI 95%: Cornfield's 95% confidence interval for the OR; ND: not determined (0% frequency); FV: factor V; FII: prothrombin; MTHFR: methylenetetrahydrofolate reductase.